Morphologic characteristics of central pulmonary thromboemboli predict haemodynamic response in massive pulmonary embolism

Intensive Care Med. 2004 Aug;30(8):1552-6. doi: 10.1007/s00134-004-2314-5. Epub 2004 Jun 12.

Abstract

Objective: On hospital admission, the morphology of the central pulmonary artery thromboemboli is an independent predictor of 30-day mortality in patients with massive pulmonary embolism (MPE). This may be due to the differential susceptibility of thromboemboli to thrombolysis. The aim of this study was to assess haemodynamic response to treatment in patients with MPE and morphologically different thromboemboli.

Design: Prospective observational study.

Setting: An 11-bed closed medical ICU at a 860-bed community general hospital.

Patients: Twelve consecutive patients with shock or hypotension due to MPE and central pulmonary thromboemboli detected by transesophageal echocardiography who were treated with thrombolysis between January 2000 through April 2002.

Procedures: Patients were divided into two groups according to the characteristics of detected central pulmonary thromboemboli: group 1, thrombi with one or more long, mobile parts; and group 2, immobile thrombi. Urokinase infusion was terminated when mixed venous oxygen saturation was stabilized above 60% for 15 min.

Results: At 2 h, the total pulmonary vascular resistance index was reduced more in group 1 than group 2 [from 27+/-12 mmHg/(l.min.m(2)) to 14+/-6 mmHg/(l.min.m(2)) (-52%) vs 27+/-8 mmHg/(l.min.m(2)) to 23+/-10 mmHg/(l.min.m(2)) (-15%), respectively, P=0.04]. In group 1 thrombolysis was terminated earlier than group 2 (89+/-40 min vs 210+/-62 min, respectively, P= 0.0024). The cumulative dose of urokinase used in group 1 was lower than group 2 (1.7+/-0.3 M i.u. vs 2.7+/-0.5 M i.u., respectively, P= 0.023).

Conclusion: Haemodynamic stabilization is achieved faster in patients with mobile central thromboemboli detected by transesophageal echocardiography during MPE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Anticoagulants / therapeutic use
  • Chi-Square Distribution
  • Critical Care
  • Echocardiography, Transesophageal*
  • Female
  • Hemodynamics
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prospective Studies
  • Pulmonary Embolism / diagnostic imaging*
  • Pulmonary Embolism / drug therapy
  • Pulmonary Embolism / mortality
  • Statistics, Nonparametric
  • Thrombolytic Therapy / methods
  • Urokinase-Type Plasminogen Activator / therapeutic use

Substances

  • Anticoagulants
  • Urokinase-Type Plasminogen Activator